Helix BioMedix, Inc. (HXBM)

OTCMKTS · Delayed Price · Currency is USD

1.700

0.00 (0.00%)

At close: Mar 3, 2026

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003	FY 2002
Period Ending	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005	Dec '04 Dec 31, 2004	Dec '03 Dec 31, 2003	Dec '02 Dec 31, 2002
Biotechnology (Startups)	1.89M	851.68K	391.27K	562.88K	463.94K
Biotechnology (Startups) Growth	122.07%	117.67%	-30.49%	21.33%	553.99%
Total	1.89M	851.68K	391.27K	562.88K	463.94K
Total Growth	122.07%	117.67%	-30.49%	21.33%	553.99%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004	FY 2003	FY 2002
Period Ending	Dec '11 Dec 31, 2011	Dec '10 Dec 31, 2010	Dec '09 Dec 31, 2009	Dec '08 Dec 31, 2008	Dec '07 Dec 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005	Dec '04 Dec 31, 2004	Dec '03 Dec 31, 2003	Dec '02 Dec 31, 2002
United States	1.89M	851.68K	391.27K	562.88K	463.94K
United States Growth	122.07%	117.67%	-30.49%	21.33%	553.99%
Total	1.89M	851.68K	391.27K	562.88K	463.94K
Total Growth	122.07%	117.67%	-30.49%	21.33%	553.99%

Source: S&P Global Market Intelligence.